Influence of Different Populations on Pharmacokinetic Bioequivalence Results: Can We Extrapolate Bioequivalence Results from One Population to Another?
Purpose: Over the last 15 years, an ever-increasing proportion of pharmacokinetic bioequivalence studies for European/North American generic submissions appeared to have been conducted in geographical/ethnic populations other than those for which the drug is marketed for. The results of pharmacokine...
Saved in:
Main Authors: | Deniz Ozdin (Author), Murray P. Ducharme (Author), France Varin (Author), Anders Fuglsang (Author), Dina Al-Numani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rethinking bioequivalence and equivalence requirements of orally inhaled drug products
by: Dina Al-Numani, et al.
Published: (2015) -
Novel Population Pharmacokinetic Method Compared to the Standard Noncompartmental Approach to Assess Bioequivalence of Iron Gluconate Formulations
by: Corinne Seng Yue, et al.
Published: (2013) -
Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations
by: Deniz Ozdin, et al.
Published: (2018) -
When Bioequivalence in Healthy Volunteers May not Translate to Bioequivalence in Patients: Differential Effects of Increased Gastric pH on the Pharmacokinetics of Levothyroxine Capsules and Tablets
by: Corinne Seng Yue, et al.
Published: (2015) -
Development of Mechanistic In Vitro-In Vivo Extrapolation to Support Bioequivalence Assessment of Long-Acting Injectables
by: Daniela Amaral Silva, et al.
Published: (2024)